Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,606.49
(
-0.27%
)
US TECH 100
23,507.20
(
-0.90%
)
Dow Jones
46,021.43
(
-0.44%
)
Brent Oil
107.16
(
2.61%
)
Bitcoin
70,305.02
(
0.58%
)
News Focus
News Focus
Post# of 257262
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122802
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: rkrw post# 88203

Saturday, 12/26/2009 10:46:22 PM

Saturday, December 26, 2009 10:46:22 PM

Post# of 257262
The new Angiomax patent is not the critical composition-of-matter patent that MDCO has been trying to get extended through bribery and other means. I doubt that the new patent will stand up to scrutiny, and it certainly won't scare off an aggressive P-IV challenger.


“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now